Health Hope Pharma

Quick facts

Phase 3 pipeline

• Encequidar tablet · Oncology
  Encequidar is a potent and selective inhibitor of P-glycoprotein.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Health Hope Pharma portfolio CI brief
• Health Hope Pharma pipeline updates RSS